Duration of AntiPlatelet Therapy for Stent Assisted Treatment of Cerebral Aneurysm Registry

Duration of AntiPlatelet Therapy for Stent Assisted Treatment of Cerebral Aneurysm Registry - DAPTS ACE-Registry

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022463

Enrollment

100

Registered

2016-05-27

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial aneurysm

Interventions

anti platelet treatment following stent assisted embol ization of intracranial aneurysm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 stent assisted embolization of intracranial aneurysm 2 receive anti platelet treatment 3 20 year old or more 4 document informed consent

Exclusion criteria

Exclusion criteria: inappropriate for this study

Design outcomes

Primary

Measure	Time frame
ischemic stroke during 15 months after stent assisted embolization of intracranial aneurysm	—

Secondary

Measure	Time frame
1 death and all stroke during 15 months after stent assisted embolization of intracranial aneurysm 2 hemorrhagic event during 15 months after stent assisted embolization of intracranial aneurysm 3 death, stake and hemorrhagic event during 15 months after stent assisted embolization of intracranial aneurysm 4 pretreatment and stenosis or occlusion go stent during 15 months after stent assisted embolization of intracranial aneurysm	—

Measure

Time frame

1 death and all stroke during 15 months after stent assisted embolization of intracranial aneurysm 2 hemorrhagic event during 15 months after stent assisted embolization of intracranial aneurysm 3 death, stake and hemorrhagic event during 15 months after stent assisted embolization of intracranial aneurysm 4 pretreatment and stenosis or occlusion go stent during 15 months after stent assisted embolization of intracranial aneurysm

—

Countries

Japan

Contacts

Public ContactSatoshi Nakagawa

Translational Research Informatics Project Management

s-nakagawa@tri-kobe.org0783039108

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026